Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis

NCT01023256 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: MOR103
DRUG: MOR103
DRUG: MOR103

Sponsor

MorphoSys AG